Dissimuler ce message

Bienvenue au Centre de Ressources sur les Entreprises et les Droits de l’Homme.

Nous nous faisons un devoir de travailler avec les militants de la société civile, les entreprises et les gouvernements afin d’aborder les inégalités de pouvoir, d’identifier les voies recours en cas d’abus, et d’assurer la protection des individus et de la planète.

Les entreprises et les communautés affectées nous remercient toutes deux des ressources et du soutien que nous leur apportons.

Ceci est uniquement possible grâce à votre soutien. S’il vous plaît, songez à faire un don dès aujourd’hui.

Merci,
Phil Bloomer, Directeur Exécutif

Faire un don maintenant Dissimuler ce message

Apotex

Apotex website

🔎 Run a search for “Apotex”

Souscrire au flux RSS de cette rubrique

Toutes les histoires

Réponse
4 September 2018

Canada : La Colombie-Britannique poursuit en justice plus de quarante groupes pharmaceutiques fabriquant ou commercialisant des opiacés à l'origine de milliers de morts

Auteur: Le Monde

« Au Canada, les fabricants d'opiacés seront poursuivis en justice », 30 août 2018...

Lire toute la réponse

Article
29 August 2018
+ English - Cacher

Auteur: Peter Robb, ipolitics (Canada)

"B.C. first government in Canada to sue drug companies over opioids", 29 Aug 2018...

Lire la suite

Article
13 April 2009
+ English - Cacher

Auteur: Michael Geist, Toronto Star [Canada]

[T]he World Trade Organization reached agreement designed to facilitate the export of medicines by opening the door to a compulsory licence for developing countries…Canada became an early adopter of the agreement by reforming the Patent Act…Several...

Lire la suite

  • Entreprises concernées: Apotex
Article
6 April 2009
+ English - Cacher

Auteur: Reuters

Andrew Bodnar, a former top executive at Bristol-Myers Squibb…faces up to a year in jail after pleading guilty to lying to federal officials about a deal to block a generic version of the company's top-selling medicine…Bristol-Myers in 2007 agreed to...

Lire la suite

Article
18 March 2009
+ English - Cacher

Auteur: Fred Mwasa, Embassy [Canada]

A generic drug company plans to halt the production and shipment of cheap life-saving HIV/AIDS pills to Africa unless changes are made to Canada's Access to Medicines Regime. Canadian generic pharmaceutical company Apotex became the first company to...

Lire la suite

  • Entreprises concernées: Apotex
Article
10 August 2007
+ English - Cacher

Auteur: Kaiser Network Daily HIV/AIDS Report [USA]

GlaxoSmithKline on Wednesday announced that it has given consent to Toronto-based drug company Apotex to use two of its patented antiretroviral drugs...to manufacture Apo-triAvir -- a fixed-dose combination of the two drugs and the antiretroviral...

Lire la suite

Article
9 August 2007
+ English - Cacher

Auteur: Amir Attaran, Professor, Institute of Population Health, University of Ottawa

As a professor of public health and law, I want to comment on Apotex's plan to sell its three-in-one AIDS medicine to Rwanda. Canada is not the best country to meet Rwanda's medicine needs, and if Apotex made the sale, it would be to Rwanda's profound...

Lire la suite

Histoire
8 August 2007
+ English - Cacher
Article
27 April 2003
+ English - Cacher

Auteur: Channel 4 television [UK]

A hard-hitting investigation into the global power of the world's most profitable business - the pharmaceutical industry...In Africa the team sees how one of the world's biggest drug companies [Pfizer] experimented on children without their parents'...

Lire la suite

Article
23 October 2001
+ English - Cacher

Auteur: Robert Fife, National Post [Canada]

...a more senior official said Mr. Rock had little choice but to come to terms with Bayer because his department had breached the drug giant's legal patent, potentially threatening the $1-billion a year the pharmaceutical industry invests in Canada....

Lire la suite